Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Scientific Update on Bruton Tyrosine Kinase Inhibitors to Improve Outcomes for Patients with Multiple Sclerosis

Program Overview

This CME program, derived from content presented at the 2022 Joint Pre-ECTRIMS Workshop in Amsterdam, the Netherlands, will delve into a scientific update on Bruton tyrosine kinase inhibitors (BTKi) to improve outcomes for patients with multiple sclerosis (MS). The expert faculty, Dr. Benjamin Greenberg, will first review recent clinical trial data for BTK inhibitor therapeutics to treat patients ...
View Course

Strategies to Identify and Manage Spasticity and Related Symptoms in Patients with Multiple Sclerosis

Program Overview

This CME program, derived from content presented at the 2022 Joint Pre-ECTRIMS Workshop in Amsterdam, the Netherlands, will highlight strategies to identify and manage spasticity in patients with multiple sclerosis (MS). The expert faculty, Dr. Fred D. Lublin, will first review the unmet needs of multiple sclerosis patients with spasticity. Next, an analysis of current and emerging clinical ...
View Course

Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer

Program Overview

This CME/CE program will highlight the application of poly (ADP-ribose) polymerase (PARP) inhibitors to improve outcomes for patients with advanced ovarian cancer. The expert faculty, led by Dr. Don Dizon, will first review updates to the National Comprehensive Care Network (NCCN) evidence-based guidelines. Next, an analysis of current and emerging clinical trial data of PARP Inhibitors will be ...
View Course

Case Studies in Optimal Management of Anti-FXa-DOAC-Associated Intracranial Hemorrhage: Specific vs Nonspecific Anticoagulant Reversal

Program Overview

This CME program is derived from content presented at the 8th European Stroke Organization Conference (ESOC 2022). This educational activity, chaired by Dr. Thorsten Steiner, will review optimal management strategies of patients with anti-FXa-DOAC-associate Intracranial Hemorrhage (ICH). The worldwide utilization of DOACs for a number of different indications has continuously increased over the past decade, and while the ...
View Course
Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities – Modules 3 & 4

Program Overview

This CME program will highlight evidence based dietary and pharmacologic approaches to manage patients with hyperkalemia. In module 3, Dr. George Bakris will analyze the clinical trial data for newer therapeutic options to treat patients with hyperkalemia. Following, Dr. Matthew Weir will lead a faculty discussion to further delve into these trials and how they relate to patient ...
View Course

Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities – Modules 1 & 2

Program Overview

This CME program will highlight evidence based dietary and pharmacologic approaches to manage patients with hyperkalemia. Starting with module 1, Dr. Biff Palmer will review the science of recurrent hyperkalemia, including relationships between dietary potassium intake, serum potassium, and patient morbidities. Next, in module 2, Dr. Pamela Kushner will evaluate the limitations and impact of plant-based diets and ...
View Course

Upcoming Events

South Carolina Neurological Association Annual Meeting

September 15th – 16th, 2023

Eastern Pulmonary Conference

September 21st – 24th, 2023

ECTRIMS Congress – MSMilan2023

October 11th – 13th, 2023

ASHP 2023 Midyear Clinical Meeting and Exhibition

December 3rd – 7th, 2023

Leave a Reply

Your email address will not be published. Required fields are marked *